Packard Center researcher and Rothstein lab member chosen as a 2023 ALS Association Milton Safenowitz Postdoctoral Fellow
Congratulations to S. Can Akerman, Ph.D, a member of the Rothstein Lab, a member of the Packard Center…
Congratulations to S. Can Akerman, Ph.D, a member of the Rothstein Lab, a member of the Packard Center…
The brothers of Delta Tau Delta fraternity at Butler University in Indianapolis, Indiana recently held a 3v3 basketball…
Researchers at The Ohio State University Wexner Medical Center and College of Medicine led the creation of evidence-based…
Reposted from the NYTimes.comBy Christopher MaagPublished Sept. 6, 2023 Dan Doctoroff once had more power to decide what got built…
Hundreds of people in the ALS community gathered in person and online for the 23rd Annual Packard Center…
ALS and FTD are complex diseases, with many steps in the disease pathways still unknown. But the two…
2023 has been a big year of change for the Packard Center. Besides a new Scientific Director, Packard…
Earlier this year, the Packard Center welcomed its new Scientific Director, Dr. Christine Vande Velde. Dr. Vande Velde…
The Food and Drug Administration granted accelerated approval of the drug tofersen for the treatment of SOD1-ALS. Developed by…
In a new paper in PLOS Genetics, Packard researcher Jiou Wang identified a new mechanism through which C9orf72…